Through the Innovation Impact award program, we seek to be the catalyst to transform dialogue into game-changing, tangible action resulting in the incorporation of the patient voice at every step of the drug discovery and development continuum.
In 2017, these were the top three winners of the Innovation Impact awards: Facing Our Risk of Cancer Empowered (FORCE), Foundation for Sarcoidosis Research and Myeloma Crowd.
This year, our generous judges also chose two runner-ups: American Gastroenterological Association and National Coalition for Cancer Survivorship (NCCS).
Facing Our Risk of Cancer Empowered (FORCE): Project DeCoDe-DEveloping COlaborative DEcision-making Guides on Hereditary Breast, Ovarian, and Related Cancers for Patients, Families and their Providers.
FORCE’s goal is to create collaborative decision-making tools to improve communication between patients, families, and healthcare providers.
Foundation for Sarcoidosis Research: SARC-ID (Sarcoidosis Institution Designation Program)
The foundation’s goal is to establish criteria by which sarcoidosis clinics can become certified as centers of excellence and develop a scorecard that tracks patients’ experiences in clinics.
Myeloma Crowd: HealthTree
Online tool/patient portal where multiple myeloma patients input their specific information and receive personally relevant treatment information such as nearby myeloma clinics, clinical trials, and treatment options.